Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens

Показать другие версии (1)

Adenoviruses are potent vectors for inducing and boosting cellular immunity to encoded recombinant antigens. However, the widespread seroprevalence of neutralizing antibodies to common human adenovirus serotypes limits their use. Simian adenoviruses do not suffer from the same drawbacks. We have con...

Полное описание

Библиографические подробности
Главные авторы:	Antrobus, R, Coughlan, L, Berthoud, T, Dicks, MD, Hill, A, Lambe, T, Gilbert, S
Формат:	Journal article
Язык:	English
Опубликовано:	Nature Publishing Group 2014

Схожие документы

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
по: Antrobus, R, и др.
Опубликовано: (2014)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
по: Folegatti, P, и др.
Опубликовано: (2019)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
по: Pedro M. Folegatti, и др.
Опубликовано: (2019-05-01)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
по: Zhang, C, и др.
Опубликовано: (2023)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
по: Cheng Zhang, и др.
Опубликовано: (2023-06-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
по: Adam Berg, и др.
Опубликовано: (2021-10-01)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
по: Dicks, M, и др.
Опубликовано: (2015)

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
по: Charlotte Davis, и др.
Опубликовано: (2024-06-01)

Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa
по: Ashley C. Beavis, и др.
Опубликовано: (2023-07-01)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
по: O'Hara, G, и др.
Опубликовано: (2012)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
по: Hermosilla, E, и др.
Опубликовано: (2022)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
по: Eduardo Hermosilla, и др.
Опубликовано: (2022-03-01)

CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination
по: Sharpe, HR, и др.
Опубликовано: (2022)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
по: Jinnam Kim, и др.
Опубликовано: (2023-04-01)

A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination
по: Tanie Natung, и др.
Опубликовано: (2023-01-01)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
по: Hannah R. Sharpe, и др.
Опубликовано: (2022-03-01)

Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant)
по: Anupa Mary Job, и др.
Опубликовано: (2022-01-01)

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
по: Ogbe, A, и др.
Опубликовано: (2022)

Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens
по: Moreira Folegatti, P
Опубликовано: (2021)

Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S
по: Bas de Laat, и др.
Опубликовано: (2022-07-01)

Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
по: Rujittika Mungmunpuntipantip, и др.
Опубликовано: (2021-11-01)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
по: Ane Ogbe, и др.
Опубликовано: (2022-04-01)

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
по: Alharbi, N, и др.
Опубликовано: (2017)

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
по: Stedman, A, и др.
Опубликовано: (2019)

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
по: Simone Barocci, и др.
Опубликовано: (2022-03-01)

Humoral immunogenicity and efficacy of a single dose of ChAdOx1 MERS vaccine candidate in dromedary camels
по: Alharbi, N, и др.
Опубликовано: (2019)

Simian adenoviruses as vaccine vectors
по: Morris, S, и др.
Опубликовано: (2016)

Simian adenoviruses as vaccine vectors
по: Morris, S, и др.
Опубликовано: (2016)

Widespread Arterial Thrombosis after ChAdOx1 nCov-19 Vaccination
по: Giorgio Berlot, и др.
Опубликовано: (2022-01-01)

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
по: Lea Krutzke, и др.
Опубликовано: (2022-07-01)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
по: Tamara Garibashvili, и др.
Опубликовано: (2022-06-01)

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.
по: Jennifer Serwanga, и др.
Опубликовано: (2024-01-01)

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a Phase 1/2 clinical trial
по: Ewer, K, и др.
Опубликовано: (2020)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
по: Marchevsky, NG, и др.
Опубликовано: (2022)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
по: Edmund G.-T. Wee, и др.
Опубликовано: (2024-08-01)

ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys
по: Neeltje van Doremalen, и др.
Опубликовано: (2022-12-01)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
по: Natalie Gabrielle Marchevsky, и др.
Опубликовано: (2022-07-01)

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
по: Tao Ni, и др.
Опубликовано: (2023-10-01)

IgA Vasculitis Following ChAdOx1 nCoV-19 Vaccination
по: Manabendra Basu, и др.
Опубликовано: (2024-01-01)

DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination
по: Gerardo Casucci, и др.
Опубликовано: (2021-06-01)